Physician profile
Trina Ebersole
NPI 1902289762
$3,085.11
in general payments reported to CMS, 2019-2025
15 companies · $483 in 2025
The $483 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $728 · 2020: $264 · 2021: $318 · 2022: $165 · 2023: $576 · 2024: $551 · 2025: $483.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,610.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,609.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rti Surgical, INC | $660.29 | 2023-2025 | |
| Sientra, INC. | $564.39 | 2020-2022 | |
| Abbvie INC. | $513.27 | 2023-2024 | Natrelle Saline-Filled Breast Implants |
| Baxter Healthcare | $194.62 | 2019 | |
| Allergan, INC. | $170.62 | 2019-2022 | |
| Motiva USA, LLC | $138.05 | 2025 | |
| Mentor Worldwide LLC | $133.29 | 2023-2024 | Artoura Breast Tissue Expander, Mentor Memorygel Resterilizable Gel Sizer |
| Axogen | $118.88 | 2019 | |
| Kci USA, INC. | $113.05 | 2019-2023 | V.A.C. Veraflo |
| Integra Lifesciences Corporation | $113.02 | 2019-2023 | Durasorb Monofilament Mesh |
| Acera Surgical, INC. | $105.62 | 2020 | |
| Acell, INC. | $90.19 | 2019 | |
| Stryker Corporation | $74.86 | 2019 | |
| Polynovo North America LLC | $71.46 | 2025 | Novosorb Btm |
| Takeda Pharmaceuticals U.S.A., INC. | $23.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Trina Ebersole listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.